ISRCTN ISRCTN88374184
DOI https://doi.org/10.1186/ISRCTN88374184
Protocol serial number 93020001
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
Funder NHS Executive Northern and Yorkshire (UK)
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
21/12/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr John Scott
Scientific

School of Population and Health Sciences
University of Newcastle upon Tyne
Newcastle upon Tyne
NE2 4HH
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesUreteric reflux is an asymptomatic malfunction in the urinary tract: when complicated by urinary infection reflux nephropathy ensues; this causes end-stage renal failure in a significant number of young adults. To prevent reflux nephropathy, reflux must be detected before infection occurs. The peak incidence for infection is in early infancy, so reflux must be detected in the newborn. Reflux is a familial condition thought to have a sibling prevalence of 40%. A detailed enquiry to elicit the presence of reflux in members of a pregnant mothers family will enable an at risk population to be mustered antenatally. These babies will be subjected to cystography at birth. To determine whether chemoprophylaxis will prevent the onset of renal scarring, babies in whom reflux is detected will be randomised into two groups; one group will be given the therapy, the other will not. Assessment will take place at 3 years and 5 years.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNeonatal diseases; Other urological and genital disease
InterventionMaintenance chemotherapy with trimethoprim 2 mg/kg daily
Intervention typeOther
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/05/1995

Eligibility

Participant type(s)Patient
Age groupNeonate
SexAll
Key inclusion criteriaPregnant mothers with a familial ureteric reflux problem
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment06/01/1993
Date of final enrolment31/05/1995

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

School of Population and Health Sciences
Newcastle upon Tyne
NE2 4HH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 09/08/1997 Yes No